An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

Gestational Diabetes Mellitus: Screening

Research to directly evaluate screening for GDM and maternal and infant health outcomes.
The most beneficial glucose thresholds for a positive screen and treatment targets.
Alternative screening methods, such as glycosylated hemoglobin (HbA1c) measurement and risk factor-based assessment.
Effect of different treatments for GDM on longer-term metabolic maternal and infant outcomes (persistent maternal glucose intolerance after delivery; type 2 diabetes and obesity in mother and infant).
Whether identifying and treating glucose intolerance before 24 weeks of gestation reduces maternal and fetal complications at delivery or leads to improved long-term health outcomes.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation.

Gestational Diabetes Mellitus: Screening Read full statement